Table 3.
Cis-regulatory eQTL datasets (enrichment p value) |
||||||
---|---|---|---|---|---|---|
Prefrontal cortex | Cortex | Cortex | Liver (Schadt | Skin (Ding | LPL (Stranger | |
(Colantuoni et al27) | (Myers et al21) | (Webster et al22) | et al23) | et al24) | et al25) | |
p<0·01 | 0·41 | 0·020 | 0·0028 | 0·37 | 0·22 | 0·11 |
p<0·1 | 0·11 | 0·020 | 0·000027 | 0·39 | 0·15 | 0·28 |
p<0·2 | 0·19 | 0·0030 | 0·000061 | 0·069 | 0·21 | 0·12 |
p<0·3 | 0·012 | 0·012 | 0·00034 | 0·013 | 0·02 | 0·066 |
p<0·4 | 0·023 | 0·0071 | 0·00030 | 0·045 | 0·044 | 0·10 |
p<0·5 | 0·023 | 0·043 | 0·0071 | 0·22 | 0·078 | 0·0068 |
Cross-disorder risk SNPs were defined as those meeting the p-value cutoffs shown in the left column in the primary meta-analysis of five disorders, and residing within 1 M bases from human reference hg18 genes.
LPL=lymphoblastoid cell lines.